AstraZeneca
AstraZeneca

Dividends • AstraZeneca

AZN

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
2/21/2025
3/24/2025
1,05
Biannual
8/9/2024
9/9/2024
0,5
Biannual
2/22/2024
3/25/2024
0,985
Biannual
8/10/2023
9/11/2023
0,465
Biannual
2/23/2023
3/27/2023
0,985
Biannual
8/11/2022
9/12/2022
0,465
Biannual
2/24/2022
3/28/2022
0,985
Biannual
8/12/2021
9/13/2021
0,45
Biannual
2/25/2021
3/29/2021
0,95
Biannual
8/13/2020
9/14/2020
0,45
Biannual
2/27/2020
3/30/2020
0,95
Biannual
8/8/2019
9/9/2019
0,45
Biannual
2/28/2019
3/27/2019
0,95
Biannual
8/9/2018
9/10/2018
0,45
Biannual
2/15/2018
3/19/2018
0,95
Biannual
8/9/2017
9/11/2017
0,45
Biannual
1/4